An anti-VEGF therapy increases the CTLs extravasation in tumor microenvironment 47; reduce T cell apoptosis induced by Fas/FasL signaling 48, and inhibit CD8 T cell exhaustion mediated by the PD-1/PDL-1 interaction 49, 50. Here, VEGFA is linked to neoplasm.